TY - JOUR
T1 - Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer
AU - Palmirotta, Raffaele
AU - Savonarola, Annalisa
AU - Ludovici, Giorgia
AU - de Marchis, Maria Laura
AU - Covello, Renato
AU - Ettorre, Giuseppe Maria
AU - Ialongo, Cristiano
AU - Guadagni, Fiorella
PY - 2011
Y1 - 2011
N2 - The K-ras gene is frequently mutated in colorectal cancer and has been associated with tumor initiation and progression; approximately 90% of the activating mutations are found in codons 12 and 13 of exon 1 and just under 5% in codon 61 located in exon 2. These mutations determine single aminoacidic substitutions in the GTPase pocket leading to a block of the GTP hydrolytic activity of the K-ras p21 protein, and therefore to its constitutive activation. Point mutations in sites of the K-ras gene, other than codons 12, 13 and 61, and other types of genetic alterations, may occur in a minority of cases, such as in the less frequent cases of double mutations in the K-ras gene. However, all mutations in this gene, even those which occur in non-canonical sites or double mutations, are relevant oncogenic alterations in colorectal cancer and may underlie K-ras pathway hyperactivation. In the present study, we report the case of a patient with colorectal cancer presenting a concurrent point mutation in exons 1 and 2 of the K-ras gene, a GGT to TGT substitution (Glycine to Cysteine) at codon 12, and a GAC to AAC substitution (Aspartic Acid to Asparagine) at codon 57. In addition, we found in the same patient's sample a silent polymorphism at codon 11 (Ala11Ala) of exon 1.
AB - The K-ras gene is frequently mutated in colorectal cancer and has been associated with tumor initiation and progression; approximately 90% of the activating mutations are found in codons 12 and 13 of exon 1 and just under 5% in codon 61 located in exon 2. These mutations determine single aminoacidic substitutions in the GTPase pocket leading to a block of the GTP hydrolytic activity of the K-ras p21 protein, and therefore to its constitutive activation. Point mutations in sites of the K-ras gene, other than codons 12, 13 and 61, and other types of genetic alterations, may occur in a minority of cases, such as in the less frequent cases of double mutations in the K-ras gene. However, all mutations in this gene, even those which occur in non-canonical sites or double mutations, are relevant oncogenic alterations in colorectal cancer and may underlie K-ras pathway hyperactivation. In the present study, we report the case of a patient with colorectal cancer presenting a concurrent point mutation in exons 1 and 2 of the K-ras gene, a GGT to TGT substitution (Glycine to Cysteine) at codon 12, and a GAC to AAC substitution (Aspartic Acid to Asparagine) at codon 57. In addition, we found in the same patient's sample a silent polymorphism at codon 11 (Ala11Ala) of exon 1.
KW - Colorectal cancer
KW - Double mutation
KW - K-ras
UR - http://www.scopus.com/inward/record.url?scp=84856809551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856809551&partnerID=8YFLogxK
U2 - 10.5603/FHC.2011.0097
DO - 10.5603/FHC.2011.0097
M3 - Article
C2 - 22252770
AN - SCOPUS:84856809551
VL - 49
SP - 729
EP - 733
JO - Folia Histochemica et Cytochemica
JF - Folia Histochemica et Cytochemica
SN - 0239-8508
IS - 4
ER -